Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yufei Xiang

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Cancer Letters|April 19, 2023
PIWI-interacting RNAs: Critical roles and therapeutic targets in cancerJialin Zhou, Han Xie, Jun Liu, et al.
Acta Diabetologica|February 22, 2012
Autoantibodies to CCL3 are of low sensitivity and specificity for the diagnosis of type 1 diabetesGan Huang, Xuxu Mo, Muwen Li, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|September 10, 2014
[Isolation, amplification and identification of human natural CD4⁺CD25⁺ regulatory T cells in vitro]Ying Hu, Xin Su, Lingjia Liu, et al.
Journal of Diabetes and Its Complications|February 2, 2026
Treatment-related progression of subclinical atherosclerosis in latent autoimmune diabetes in adults: A two-year longitudinal studyYufei Xiang, Xiaohan Tang, Yang Xiao, et al.
Cell Systems|February 16, 2021
Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodiesYufei Xiang, Zhe Sang, Lirane Bitton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD miceYufei Xiang, Jian Peng, Ningwen Tai, et al.
Diabetes Care|January 2, 2016
Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in AdultsChao Deng, Yufei Xiang, Tingting Tan, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
Reduced antigenicity of Omicron lowers host serologic responseJérôme Tubiana, Yufei Xiang, Li Fan, et al.
Frontiers in Immunology|December 1, 2022
Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic originJunlin Qiu, Shuoming Luo, Wenfeng Yin, et al.
Cell Reports|October 12, 2022
Reduced B cell antigenicity of Omicron lowers host serologic responseJérôme Tubiana, Yufei Xiang, Li Fan, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Cancer Letters|April 19, 2023
PIWI-interacting RNAs: Critical roles and therapeutic targets in cancerJialin Zhou, Han Xie, Jun Liu, et al.
Acta Diabetologica|February 22, 2012
Autoantibodies to CCL3 are of low sensitivity and specificity for the diagnosis of type 1 diabetesGan Huang, Xuxu Mo, Muwen Li, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|September 10, 2014
[Isolation, amplification and identification of human natural CD4⁺CD25⁺ regulatory T cells in vitro]Ying Hu, Xin Su, Lingjia Liu, et al.
Journal of Diabetes and Its Complications|February 2, 2026
Treatment-related progression of subclinical atherosclerosis in latent autoimmune diabetes in adults: A two-year longitudinal studyYufei Xiang, Xiaohan Tang, Yang Xiao, et al.
Cell Systems|February 16, 2021
Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodiesYufei Xiang, Zhe Sang, Lirane Bitton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD miceYufei Xiang, Jian Peng, Ningwen Tai, et al.
Diabetes Care|January 2, 2016
Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in AdultsChao Deng, Yufei Xiang, Tingting Tan, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
Reduced antigenicity of Omicron lowers host serologic responseJérôme Tubiana, Yufei Xiang, Li Fan, et al.
Frontiers in Immunology|December 1, 2022
Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic originJunlin Qiu, Shuoming Luo, Wenfeng Yin, et al.
Cell Reports|October 12, 2022
Reduced B cell antigenicity of Omicron lowers host serologic responseJérôme Tubiana, Yufei Xiang, Li Fan, et al.
Pageof 9